Tetra-Gel: Customize Hydrogels for Your Regenerative Medicine Needs
Gellycle Co., Ltd.
Tetra-Gel
Precise Control of Gelation, Degradation & Mechanical Properties
Tetra Gel is an advanced hydrogel formed by the simple combination of branched polyethylene glycol (PEG), featuring a uniform mesh structure.
This core technology enables precise control over hydrogel properties such as :
ーgelation time, degradation time
ーhardness, swelling, elasticity
ーsprayability and pore size, etc..
Result: It offers a versatile gel suitable for bone/tendon regeneration, drug delivery, wound care, and beyond.
Bone Regeneration
Bone Regeneration with Tetra-gel
Tetra-gel can be precisely tuned for degradation time and mesh size, enabling controlled controlled drug release at targeted time points.
By leveraging these features, it has been successfully applied to promote bone regeneration.
By leveraging these features, it has been successfully applied to promote bone regeneration.
Tendon Regeneration Mechanism
Tendon Regeneration & Cell therapy with Tetra-gel
Current limitations: Traditional methods fail to fully regenerate severed tendons.
Tetra-Gel provides a novel dual solution:
- Barrier function: Prevents external cell invasion and adhesion, enabling intrinsic healing only
- Cell therapy: Encapsulates cells to actively promote tendon regeneration. This cell encapsulation approach is also applicable to broader regenerative medicine applications, such as cartilage, bone, or skin repair, by protecting and delivering therapeutic cells precisely to diverse target tissues
Tetra-Gel provides a novel dual solution:
- Barrier function: Prevents external cell invasion and adhesion, enabling intrinsic healing only
- Cell therapy: Encapsulates cells to actively promote tendon regeneration. This cell encapsulation approach is also applicable to broader regenerative medicine applications, such as cartilage, bone, or skin repair, by protecting and delivering therapeutic cells precisely to diverse target tissues
Controlled Drug Delivery Mechanism
Controlled Drug Delivery with Tetra-gel
Current limitations: Injected drug solutions rapidly diffuse to off-target tissues, reducing efficacy.
Tetra-Gel Solution:
- Precise localization: Controls biodegradation time and mesh size to retain drugs at target site
- Sustained release: Delivers therapeutics to intended tissues/cells over customizable timeframes
- Versatile carriers: Effective for viruses, growth factors, and small molecules
Tetra-Gel Solution:
- Precise localization: Controls biodegradation time and mesh size to retain drugs at target site
- Sustained release: Delivers therapeutics to intended tissues/cells over customizable timeframes
- Versatile carriers: Effective for viruses, growth factors, and small molecules
Business Model
Explore Collaborative Development with Us
Collaboration Opportunities
We collaborate with clients to develop new medical products using our Tetra-Gel technology. Our collaboration pipeline includes bone regeneration, tendon regeneration, nerve regeneration, anti-adhesion materials, wound dressings, and drug delivery control.
We have been collaborating with over 40 partners and researchers worldwide to advance Tetra-Gel technology into practical medical applications.
By partnering with us, you can co-develop innovative products using our gel technology—products you can brand and commercialize as your own.
Together, we've demonstrated proof-of-concept success through preliminary experiments and international joint research, addressing critical unmet medical needs.
Business Model
We are open to merging our technology with your ideas to create new development opportunities for joint projects. Let's co-create the future of gel medicine together.
Before formal collaboration, we can provide gel samples for preliminary experiments. Please feel free to contact us for more details.
We collaborate with clients to develop new medical products using our Tetra-Gel technology. Our collaboration pipeline includes bone regeneration, tendon regeneration, nerve regeneration, anti-adhesion materials, wound dressings, and drug delivery control.
We have been collaborating with over 40 partners and researchers worldwide to advance Tetra-Gel technology into practical medical applications.
By partnering with us, you can co-develop innovative products using our gel technology—products you can brand and commercialize as your own.
Together, we've demonstrated proof-of-concept success through preliminary experiments and international joint research, addressing critical unmet medical needs.
Business Model
We are open to merging our technology with your ideas to create new development opportunities for joint projects. Let's co-create the future of gel medicine together.
Before formal collaboration, we can provide gel samples for preliminary experiments. Please feel free to contact us for more details.
- URL (Japanese):https://gellycle.com/home
- URL (English):https://gellycle.com/home-en